当前位置:Public Access >页面
Chinese/English
The clinical study of anlotinib combined with chemotherapy as the second-line treatment of non-small cell lung cancer
Filter Options
Patient No. Patient Name Patient Gender
Sitting Education Date of enrollment FromTo
       More Options
Patient No Gender Date of enrollment Sitting Creater Operate
NO participants recorded。